<p>Exenatide once a week versus placebo as a potential diseasemodifying treatment for people with Parkinson’s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial #Neurology #Parkinson</p>

Exenatide once a week versus placebo as a potential diseasemodifying treatment for people with Parkinson’s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial #Neurology #Parkinson

Exenatide in Parkinson’s disease phase 3 trial

A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.

Share Exenatide in Parkinson’s disease phase 3 trial

Sign up to save your podcasts

Exenatide in Parkinson’s disease phase 3 trial

Exenatide in Parkinson’s disease phase 3 trial